Delivra Health Brands Inc.
FRC CoverageDelivra Health Brands Inc.
FRC CoverageYour view on DHB.V
Overview
What the company does, where it operates, and who runs it.
*Delivra Health Brands Inc. has paid FRC a fee for research coverage and distribution of reports.
About Delivra Health Brands Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Gord Davey
- Headquarters
- 999 Canada Place Suite 404, Vancouver, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Gord Davey
- Headquarters
- 999 Canada Place Suite 404, Vancouver, BC, CA
Delivra Health Brands Inc., through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide. It offers liquid sleep shots, gummies, and sleep powder packets, as well as pain relief creams under the Dream Water, LivRelief, and Dream Water brands. The company was formerly known as Harvest One Cannabis Inc.
Middle East Freeze Sparks Deep Value Discount
Sign in to view
Middle East Freeze Sparks Deep Value Discount
Sign in to view
Research Reports
FRC analyst coverage and recommendations.
Past Reports
Historical coverage archive.
Analyst Notes
Ongoing commentary and updates from FRC analysts.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Delivra Health Brands Inc., and the rating behind it. DHB.V last traded at C$0.29; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Delivra Health Brands Inc.. Starting points for Delivra Health Brands Inc.: EPS -C$0.03, beta 0.99 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Delivra Health Brands Inc.. Delivra Health Brands Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Delivra Health Brands Inc.. Trailing twelve-month EPS for Delivra Health Brands Inc. stands at -C$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Delivra Health Brands Inc.. Delivra Health Brands Inc. has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Delivra Health Brands Inc. valued side by side against its closest peers. Delivra Health Brands Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Delivra Health Brands Inc., and how their positions are changing. At a C$9.1M market value, institutional positions materially move Delivra Health Brands Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Delivra Health Brands Inc. executives and directors. Shares of Delivra Health Brands Inc. have traded between C$0.11 and C$0.37 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Delivra Health Brands Inc.. Delivra Health Brands Inc. is a C$9.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Delivra Health Brands Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Delivra Health Brands Inc.. Coverage tracks Delivra Health Brands Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.
